Raptor Pharmaceutical to Hold Fourth Quarter and Full Year 2013 Financial Results Webcast and Conference Call
10 mars 2014 07h30 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., March 10, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will release fourth quarter and full year 2013 financial results after market close...
Raptor Pharmaceutical to Present at Two Upcoming Investor Conferences
24 févr. 2014 07h30 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Feb. 24, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that company management will present at two upcoming investor conferences.
JMP...
Raptor Submits IND for RP103 for Leigh Syndrome and Other Mitochondrial Disorders
10 déc. 2013 07h30 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Dec. 10, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it has submitted an investigational new drug application (IND) to the U.S. Food and...
Raptor Pharmaceutical Corp. Provides PROCYSBI(R) Launch Update and Third Quarter 2013 Financial Results
07 nov. 2013 16h05 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Nov. 7, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today provided financial results for its third quarter and nine months ended September 30, 2013.
PROCYSBI...
Raptor Pharmaceuticals and DaVita Clinical Research Launch Screening Program to Identify Patients With Late Onset Nephropathic Cystinosis
23 oct. 2013 07h30 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Oct. 23, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) and DaVita Clinical Research® (DCR®) (NYSE:DVA) today announced a collaboration to screen blood...
Raptor Pharmaceutical to Hold Third Quarter 2013 Financial Results Webcast and Conference Call
21 oct. 2013 07h30 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Oct. 21, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will release third quarter 2013 financial results after market close on Thursday,...
Raptor Pharmaceutical to Present at Leerink Swann Rare Disease Roundtable
26 sept. 2013 07h30 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Sept. 26, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced management will present at the Leerink Swann Rare Disease Roundtable in New York on October...
Raptor Pharmaceutical Receives Marketing Authorization for PROCYSBI(R) in European Union
12 sept. 2013 07h30 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Sept. 12, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the European Commission (EC) has approved PROCYSBI® gastro-resistant hard...
Raptor Pharmaceutical Announces Presentation at the International Pediatric Nephrology Association Meeting in Shanghai
29 août 2013 07h30 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Aug. 29, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that PROCYSBI (cysteamine bitartrate) will be featured in an upcoming presentation at the...
Raptor Pharmaceutical Provides PROCYSBI(TM) Launch Update and Second Quarter 2013 Financial Results
08 août 2013 16h05 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Aug. 8, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today provided a launch update for PROCYSBI (cysteamine bitartrate) delayed-release capsules and financial...